Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Classificação em ações #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Preço da ação
$0.01292666
Última sincronização: 2025-04-08
Valor de mercado
$157.54K
Variação (1 dia)
6.84%
Variação (1 ano)
0.00%
País
GB
Negociar Synairgen plc (SNG)

Categoria

Histórico de preços das ações de Synairgen plc (SNG)
Preço de fecho mais alto: $0.01 em 2025-04-01

Preço de fecho mais baixo: $2.04 em 2004-10-01
Histórico de preços das ações da Synairgen plc de 2004 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2025 -66.26%
2024 -44.21%
2023 -52.93%
2022 -92.61%
2021 77.16%
2020 1,567.16%
2019 -48.13%
2018 14.84%
2017 -14.89%
2016 -49.84%
2015 -35.02%
2014 -37.63%
2013 15.10%
2012 50.92%
2011 14.84%
2010 -28.85%
2009 88.33%
2008 -77.12%
2007 -24.86%
2006 -99.32%
2005 209.00%
2004 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE